FMTX Stock Recent News
FMTX LATEST HEADLINES
Forma Therapeutics Holdings, Inc. (FMTX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics to Present at the Jefferies Healthcare Conference
Forma Therapeutics Holdings Inc. (NASDAQ:FMTX ) Q1 2022 Earnings Conference Call May 6, 2022 8:00 AM ET Company Participants Frank Lee – President and Chief Executive Officer Mario Corso – Senior Director Investor Relations Patrick Kelly – Chief Medical Officer Dave Cook – Chief Scientific Officer Conference Call Participants Maury Raycroft – Jefferies Mark Breidenbach – Oppenheimer Robin Garner – Craig Hallum Operator Welcome to the Forma Therapeutics, First Quarter 2022 Financial Results and Business Update Conference Call. All participants are currently in listen-only mode.
WATERTOWN, Mass.--(BUSINESS WIRE)--Forma Therapeutics to Report First Quarter 2022 Financial Results and Provide Business Update on May 6, 2022